CN Patent
CN113336758B — 化合物7-碘吡咯并[2,1-f][1,2,4]三嗪-4-胺的一种新合成方法
Assigned to Beijing Chempion Pharmaceutical Technology Co ltd · Expires 2022-08-19 · 4y expired
What this patent protects
本发明提供了一种制备式(I)所示的三嗪化合物的方法。本发明以丙酮酸与甲脒为起始物料,合成中间体 经两步反应即可得到如式(I)所示的化合物。本发明提供的方法条件温和,操作简便,大大降低了成本,适于工业化大生产。
USPTO Abstract
本发明提供了一种制备式(I)所示的三嗪化合物的方法。本发明以丙酮酸与甲脒为起始物料,合成中间体 经两步反应即可得到如式(I)所示的化合物。本发明提供的方法条件温和,操作简便,大大降低了成本,适于工业化大生产。
Drugs covered by this patent
- Veklury (remdesivir) · Gilead Sciences
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.